INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 5 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,024,181 | -0.9% | 127,267 | +27.9% | 0.01% | 0.0% |
| Q2 2023 | $4,059,117 | -1.3% | 99,537 | -9.8% | 0.01% | 0.0% |
| Q1 2023 | $4,113,339 | +54.3% | 110,366 | +44.5% | 0.01% | +60.0% |
| Q4 2022 | $2,665,525 | -42.1% | 76,398 | -7.2% | 0.01% | -50.0% |
| Q3 2022 | $4,607,000 | -21.7% | 82,367 | -27.6% | 0.01% | -16.7% |
| Q2 2022 | $5,885,000 | -27.3% | 113,726 | +2.1% | 0.01% | -14.3% |
| Q1 2022 | $8,095,000 | -11.0% | 111,420 | +44.9% | 0.01% | -6.7% |
| Q4 2021 | $9,091,000 | +104.7% | 76,894 | +132.1% | 0.02% | +87.5% |
| Q3 2021 | $4,442,000 | -2.0% | 33,131 | +18.3% | 0.01% | 0.0% |
| Q2 2021 | $4,532,000 | +5.5% | 27,997 | -47.7% | 0.01% | 0.0% |
| Q1 2021 | $4,294,000 | -9.9% | 53,517 | -38.9% | 0.01% | -11.1% |
| Q4 2020 | $4,767,000 | +3379.6% | 87,573 | +803.0% | 0.01% | – |
| Q1 2017 | $137,000 | – | 9,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |